Elena R Lebedeva Selected Research

Monoclonal Antibodies

1/2023

Safety and tolerability of monoclonal antibodies targeting the CGRP pathway and gepants in migraine prevention: A systematic review and network meta-analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elena R Lebedeva Research Topics

Disease

2	Migraine Disorders (Migraine) 01/2023 - 03/2017
2	Infarction (Infarctions) 07/2018 - 01/2018
2	Ischemia 07/2018 - 01/2018
1	Epilepsy (Aura) 01/2023
1	Headache (Headaches) 01/2021
1	Headache Disorders (Headache Syndromes) 01/2018
1	Migraine with Aura (Familial Hemiplegic Migraine) 01/2018
1	Intracranial Aneurysm (Cerebral Aneurysm) 10/2007

Drug/Important Bio-Agent (IBA)

2	Retinaldehyde (Retinal)IBA 07/2018 - 01/2018
1	atogepantIBA 01/2023
1	rimegepant sulfateIBA 01/2023
1	Calcitonin Gene-Related PeptideIBA 01/2023
1	Calcitonin Gene-Related Peptide Receptor AntagonistsIBA 01/2023
1	Monoclonal AntibodiesIBA 01/2023
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2023
1	fremanezumabIBA 01/2023
1	erenumabIBA 01/2023
1	galcanezumabIBA 01/2023
1	eptinezumabIBA 01/2023
1	SolutionsIBA 01/2021
1	Pemetrexed (MTA)FDA Link 01/2018
1	Tryptamines (Triptans)IBA 03/2017
1	DNA (Deoxyribonucleic Acid)IBA 10/2007
1	Kallikreins (Kallikrein)IBA 10/2007

Therapy/Procedure

1	Therapeutics 01/2023